AJAdrienne L. Johnson

Adrienne L. Johnson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrienne L. Johnson has a total of 169 co-authors. Here are the top co-authors by number of shared publications:

  • Alison C. McLeish

    Department of Psychology, University of Cincinnati, PO Box 210376, Cincinnati, OH 45221-0376, USA; Department of Psychological and Brain Sciences, University of Louisville, Louisville, KY 40292, USA

    6 shared publications
  • Alison C. McLeish

    Department of Psychology, University of Cincinnati, PO Box 210376, Cincinnati, OH 45221-0376, USA

    5 shared publications
  • Timothy B. Baker

    Center for Tobacco Research and Intervention School of Medicine and Public Health University of Wisconsin Madison Wisconsin USA

    5 shared publications
  • Emre Umucu

    The University of Texas at El Paso

    4 shared publications
  • Kristen M. Kraemer

    A Department of Psychology , University of Cincinnati , Cincinnati , OH , USA

    4 shared publications
  • Megan E. Piper

    University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    4 shared publications

Latest Publications

  • Recommendations for reporting adult ages in tobacco research: a product of the Treatment Research Network from the Society for Research on Nicotine and Tobacco

    by Adrienne L Johnson, Jaqueline C Avila, Margaret C Fahey, Hasmeena Kathuria, Bethea A Kleykamp, Jessica A Kuluk, Nancy A Rigotti, Andrea C Villanti, Brian Williams, Alana M Rojewski

  • Open Access

    Addressing menthol cigarette use among black adults in the U.S. for health equity and racial justice

    by Cara M. Murphy, Nancy C. Jao, Mignonne C. Guy, Kelly M. Carpenter, Adrienne L. Johnson, Julia N. Soulakova, Krysten W. Bold

    In the United States (U.S.), most Black adults who smoke use menthol cigarettes, resulting in significant health disparities. Factors such as predatory targeting of Black individuals by the tobacco industry and systemic racism contribute to disproportionate use of menthol cigarettes. Despite policies banning all other flavored cigarettes, menthol cigarettes remain available, leaving Black adults and youth at risk. Menthol makes cigarettes more appealing and easier to smoke and can lead to greater nicotine dependence. Black adults who smoke menthol cigarettes are less likely to quit successfully, even though they attempt to quit at similar rates as others. Yet, research on how to help Black adults quit menthol cigarettes is lacking. To address this, there is a need for research that provides better assessment of menthol use, disentangles the effects of menthol cigarettes and race, and informs clinical guidelines with resources specifically for quitting menthol cigarettes. Additionally, community input from those who smoke menthol cigarettes is crucial to informing research design and understanding the appeal of menthol cigarettes and barriers to quitting. Interdisciplinary studies are essential to recognize the diversity among Black adults and address the unique challenges posed by menthol smoking. In April 2022, the U.S. Food and Drug Administration (FDA) announced plans to ban menthol cigarettes based on extensive scientific evidence. Yet, this has not been implemented, leading to continued health disparities, morbidity, and mortality among Black individuals. Innovative, anti-racist research is needed to move research, clinical science, treatment, and policy forward to help Black adults who smoke menthol cigarettes quit smoking.

  • Association between central adiposity and cognitive domain function in recently postmenopausal women: an analysis from the KEEPS-Cog substudy of the Kronos Early Estrogen Preventive Study

    by Taryn T. James, N. Maritza Dowling, Carola Ferrer Simó, Hector Salazar, Carol A. Van Hulle, Gilda Ennis, Adrienne L. Johnson, Mary F. Wyman, Lauren W. Y. McLester-Davis, Diane C. Gooding, et al.

    Objective: To determine associations between central adiposity, cognitive function, and randomized menopausal hormone therapy (MHT) in a reanalysis of the Kronos Early Estrogen Prevention Study-Cognitive and Affective (KEEPS-Cog) sub-study participants. Methods: KEEPS randomized 727 women (ages 42-58) who were 35 kg/m 2 , coronary artery calcium score >50 Agatston Units, and other cardiometabolic disease risk indicators were excluded from enrollment. In the ancillary KEEPS-Cog study, cognitive tests were completed at baseline, 18-, 36-, and 48-month post-randomization. In these analyses, cognitive variables were summarized as four cognitive domain-specific factor scores: verbal learning and memory, auditory attention and working memory, visual attention and executive function, and speeded language and mental flexibility. Waist-hip-ratio (WHR), an indicator of central adiposity, was measured at screening (baseline) and modeled as a covariate in linear latent growth models assessing associations of MHT with cognitive functions at baseline and over time. Results: Higher baseline WHR was associated with poorer performance on all domain-specific cognitive outcomes at baseline and with changes in visual attention and executive function across time. Models including interaction effects were not significant for either o-CEE x WHR or t-E2 x WHR. Conclusion: Central adiposity is a risk factor for domain-specific cognitive decline, and thus, cognitive health effects should be investigated in early postmenopausal women, even in women with low cardiovascular risk statuses.


  • Open Access

    A Model for Implementing Psychotherapy for Individuals with Cognitive Impairments

    by Adrienne L Johnson, Mary F. Wyman, Nathaniel A. Chin

    Individuals with Mild Cognitive Impairment (MCI) and dementia are at greater risk for mental health conditions including depression and anxiety than those without cognitive impairments.1,2 Non‐pharmacological interventions are considered first‐line to address these problems, but access to psychotherapy services for these groups remains limited. Adapted evidence‐based therapy approaches, including Cognitive Behavioral Therapy (CBT)3‐5 and Acceptance and Commitment Therapy (ACT)6 are effective for treating comorbid mental health conditions in populations with cognitive impairments. We report on the implementation of psychotherapy services for patients with MCI and Mild Dementia within the Memory Assessment Clinic of a large academic healthcare system in Midwest U.S. Pre‐implementation process included identifying a clinic champion to support adoption and observing current clinic flow by the practitioner (a licensed Clinical Health Psychologist with expertise treating patients with neurological issues) to determine logistics. Referrals were initially solely provided by the clinic champion, then opened to the entire clinic with pre‐determined eligibility guidelines: recent MCI or Mild Dementia diagnosis, comorbid anxiety or depressive symptoms, and lack of rapid forgetting in during medical examination. Therapy patients were seen on a short‐term basis (6‐8, 45‐minute sessions) to maximize access for as many patients as possible, using CBT or ACT‐based therapy modalities. Therapy content was tailored and person‐centered but included (in chronological order): evaluation of cognitive capacities to leverage during therapy, identification of treatment goals, identification of problematic cognitions/behaviors, introduction of new treatment content/coping skills (one topic/session), assign homework assignments using learned skills, evaluation of homework effectiveness and roadblocks. The initial session was in‐person to facilitate comprehensive evaluation and build rapport, and family caregivers were included as indicated. Follow‐up sessions were provided in‐person or via telehealth. Barriers to implementation included incorrect use of referral process, lack of provider knowledge of new services, and limited provider availability. Facilitators included developing a wait list for referred patients and regular education to providers with written details of the service (e.g., referral process and eligibility; waitlist duration). Similar strategies have been used in other health systems and suggest the feasibility of incorporating psychological treatment for cognitively impaired patients as part of a multi‐component treatment model.

  • Engaging Specific Populations With Tobacco-Related Health Disparities in Treatment Research: A Summary of a Society for Research on Nicotine and Tobacco Treatment Research Network Preconference Workshop

    by Adrienne L Johnson, Thanh Cong Bui, Chris Bullen, Michael Businelle, Dana Mowls Carroll, Virmarie Correa-Fernández, Wyatt Pickner, Claire A Spears, Katrina Vickerman, Damon J Vidrine, et al.


  • Examination of a hope- and fear-based message targeting older adults who smoke: A randomized trial

    by Adrienne L. Johnson, Lucy Popova, Jesse T. Kaye, Jane Mahoney

  • Open Access

    COVID‐19 outcomes among patients with dementia and age‐matched controls who were hospitalized in 21 US health‐care systems

    by Adrienne L. Johnson, Nathaniel A. Chin, Thomas M. Piasecki, Karen L. Conner, Timothy B. Baker, Michael C. Fiore, Wendy S. Slutske

    INTRODUCTION: COVID‐19 had devastating impacts worldwide. However, most research examining the impact of dementia on COVID‐19 outcomes has been conducted in Europe and Asia and has not examined dementia subtypes.METHODS: A retrospective analysis of electronic health record data from 21 US health‐care systems examined relationships of all‐cause dementia, Alzheimer's disease (AD), and vascular dementia with in‐hospital mortality, intensive care unit (ICU) admission, and hospital stay duration.RESULTS: All‐cause dementia, but not AD or vascular dementia independently, was associated with increased mortality risk, the inclusion of discharge to hospice as a mortality equivalent increased risk for mortality for all‐cause dementia, and AD and vascular dementia. Patients with all‐cause dementia and AD were less likely to be admitted to the ICU than patients without. Patients with any form of dementia had longer hospital stays than patients without.DISCUSSION: Dementia was associated with increased mortality or hospice discharge, decreased ICU admissions, and longer hospital stays.Highlights: Only all‐cause dementia was associated with increased mortality risk. This risk was lower than what has been published in previous research. Combining mortality and hospice discharge increased risk for all dementia subtypes. All‐cause and Alzheimer's disease (AD) dementia were associated with decreased intensive care unit admissions. All‐cause, vascular, and AD dementia were associated with longer hospital stays.


  • Open Access

    Qualitative Message Development to Motivate Quitting Smoking in Older Adults: Dementia May Motivate Quitting

    by Adrienne L. Johnson, Sara Doyle, Carey E. Gleason, Jessica Cook, Jane Mahoney, Megan E. Piper

    Compared to younger adults, older adults who smoke cigarettes are half as likely to make a quit attempt, but more likely to maintain abstinence using evidence-based smoking treatments (EBSTs), illustrating the need for motivational messages to promote cessation through EBSTs. It is unclear whether messaging regarding the association between smoking and dementia might motivate older adults to quit. We conducted 90-min semi-structured qualitative interviews and surveys via telephone with 24 U.S. older adults who smoke (ages 50-75) with no cognitive impairment history. Rapid content analysis revealed the most reported health-related concern of aging was dementia/cognitive loss/loss of functioning. However, most participants were unaware of the association between cognitive decline and smoking. Participants had seen previous smoking cessation advertisements, but most did not feel motivated to quit by them. The majority found a message about smoking raising dementia risk and quitting decreasing that risk to be motivational for cessation. Exact message content preference varied, but 2 broad categories arose: hope- and fear-based messages. Most participants stated willingness to use some cessation pharmacotherapy and half were willing to use cessation counseling. Participants preferred messages to come from older adults who were successful quitters. To our knowledge, this was the first study to explore potential motivational messages targeting older adult smokers, including the potential acceptability of a dementia-related message in this context. This work supports patient desire for targeted motivational messages for older adult smokers. Messages highlighting the link between smoking and dementia are perceived to be motivational for this group; future work should compare a hope- to fear-based messages.


  • Open Access

    Family Caregiving in a Great Lakes Native American Community: A Mixed Methods Study of Service Utilization

    by Mary F. Wyman, Nickolas H. Lambrou, Jordan P. Lewis, Haley M. Buerger‐Cole, Colin Hammock, Kristianna Klammer, Sacheen L. Lawrence, Debra A. Miller, Florence Petri, Joseph D. Perzynski, et al.

    Background: Native Americans are disproportionately impacted by ADRD, and family caregiving is uniquely significant within Indigenous communities. Caregiving services can improve outcomes but are underutilized, and increasing use of caregiver services is key to addressing the dementia care crisis. Indigenous populations are underrepresented in the ADRD caregiving literature, resulting in a significant gap in understanding of how to improve engagement with services. We examine perspectives on service utilization among caregivers in a large tribal nation in the US Great Lakes region.Method: Within a community‐based research partnership between the Wisconsin ADRC and the Oneida Nation of Wisconsin, N = 481 completed a survey on use of seven common caregiver resources, including support groups, respite, caregiver training, household help, transportation for care recipient, nursing home, and financial assistance. Drawing on the Andersen model of utilization, multiple regression models examined correlates of positive attitudes toward use of services among caregivers (N = 207), defined as past, current, or intended future use of services. Follow‐up in‐depth interviews with 10 caregivers of elders with ADRD (Table 3) explored decision‐making regarding service utilization using qualitative content analysis.Result: There were few demographic differences between caregivers and non‐caregivers in the sample (Mage = 52 and 54 yrs; 75% female; Table 1). Over half (54.6%) of caregivers were employed; most (64%) cared for someone with ADRD. In the final regression model in the caregiver subsample, only level of belief that traditional Oneida values and practices support caregivers in using caregiver services predicted positive attitudes toward service utilization (p<.001; Table 2). Interviews revealed barriers to service use include low awareness, complexities of service funding structures, and Elder preferences. Perceptions of alignment of traditional cultural values with service use were complex and nuanced.Conclusion: Using mixed methods in a Native American community sample, we identified unique barriers to access resources to support elders with ADRD and their families, including perceived cultural support for service use. Our findings contribute to the scant literature on ADRD caregiving among Native Americans and provide support for tailored interventions (e.g., Savvy Caregiver in Indian Country). Results can inform public health initiatives to address ADRD disparities and improve outcomes for Indigenous persons with ADRD.

  • Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer’s Disease and Related Dementias

    by Adrienne L Johnson, Elaina Seep, Derek L Norton, Marlon P Mundt, Mary F Wyman, Taryn T James, Megan Zuelsdorff, Nickolas H Lambrou, Lauren W Y McLester-Davis, Emre Umucu, et al.

    Individuals with Alzheimer’s disease and related dementias (ADRD) accrue higher healthcare utilization costs than peers without ADRD, but incremental costs of ADRD among American Indians/Alaska Natives (AI/AN) is unknown. State-wide paid electronic health record data were retrospectively analyzed using percentile-based bootstrapped 95% confidence intervals of the weighted mean difference of total 5-year billed costs to compare total accrued for non-Tribal and Indian Health Service utilization costs among Medicaid and state program eligible AI/AN, ≥40 years, based on the presence/absence of ADRD (matching by demographic and medical factors). AI/AN individuals with ADRD accrued double the costs compared to those without ADRD, costing an additional $880.45 million to $1.91 billion/year.